H.6.Investigation summary: this statement is to summarize the investigation results regarding a complaint that alleges mix of product issue when using bd veritor¿ sars-cov-2 and flu a+b (material # 256088), batch numbers 3193518.The customer reported that they ordered 5 triplex kits and two of the triplex kits came with covid only testing cartridges, instead of the triplex testing cartridges.The extraction tubes were the correct covid/flu combo, only the cassettes were incorrect.Bd quality performs a systematic approach to investigate mix of product complaints.This approach involves review of manufacturing batch history records, testing of retention samples, and testing of customer returned samples, if applicable.Batch history record (bhr) review and retain sample analysis were performed on the batch number provided.Results were acceptable and no relevant issue was found.There are no risks of product mix identified via bhr review and retention sample check.No physical samples were received; therefore, return sample analysis could not be performed.However, the customer shared the photographs of affected kit confirming that they received covid only cartridges inside instead of the triplex test cartridge in the triplex kits.This complaint was confirmed based on the photographic evidence.Based on the information provided at this moment, no root cause was identified.Currently no adverse trend for mix of product was identified.Bd quality will continue to closely monitor for trends.If you have any additional questions or concerns, please do not hesitate to contact bd technical services.The following fields have been updated with corrected and/or additional information.B5.Describe event: it was reported that two bd veritor ¿ sars-cov-2 & flu a+b kits had bd veritor ¿ sars-cov-2 cartridges inside the box.No patient impact reported.H3 other text : see h.10.
|